contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


izafe-group-in-collaboration-with-atea-sweden-has-won-a-procurement-potentially-worth-42-52-msek

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

iZafe Group is a Life Science company focused on the development and marketing of digital medical solutions for home medication management. The company offers, among other things, a medication robot, SaaS solutions and a connected dosing bag. The products aim to reduce the risk of medication errors. Customers include individuals, pharmaceutical companies and public and private healthcare providers globally. iZafe Group is headquartered in Stockholm.

Izafe Group

iZafe Group AB ("iZafe Group") announces that, in partnership with Atea Sverige AB, they have been awarded a contract with Västra Götalandsregionen for the provision of iZafe's medication dispensers...

<div class="mfn-preamble"><p><strong>iZafe Group AB ("iZafe Group") announces that, in partnership with Atea Sverige AB, they have been awarded a contract with Västra Götalandsregionen for the provision of iZafe's medication dispensers, Dosell. The contract covers 1,800 units, up to a maximum of 2,250 units, with an estimated value of 42–52 MSEK. The agreement is held by Atea Sverige AB.</strong></p></div><div class="mfn-body"><p>The contract term is for two years, with the possibility of a further two-year extension, and the contract will be signed no earlier than after a period of 10 days, which is the time that must elapse after awarding, according to procurement regulations, before a contract can be signed.<br>This is merely a decision of award and is not legally binding until a contract has been entered into.</p></div><div class="mfn-footer mfn-contacts mfn-56636653838f"><p><strong class="mfn-heading-1">Contacts</strong></p><hr><p>Anders&nbsp;Segerström, Chief Executive Officer&nbsp;<br>E-mail: <a rel="noopener" href="mailto:anders.segerstrom@izafegroup.com">anders.segerstrom@izafegroup.com</a><br>Phone&nbsp;number: <a rel="noopener">+46 70-875 14 12</a><br><br>iZafe Group AB (publ.) <br>David Bagares gata 3<br>111 38 Stockholm</p><p>E-mail:&nbsp;<a rel="noopener" href="mailto:ir@izafegroup.com">ir@izafegroup.com</a><br><a rel="noopener" href="https://izafe.se/en/">www.izafegroup.com</a><br><a rel="noopener" href="https://eucaps.com/izafe-group">eucaps.com/izafe-group</a></p></div><div class="mfn-footer mfn-about mfn-2ae9e9120422"><p><strong class="mfn-heading-1">About iZafe Group AB (publ.)</strong></p><hr><p>iZafe Group is a Life Science company that conducts research, development and marketing of digital medical solutions and services for safer medication management at home.</p><p>The company leads the development of digital drug dispensing through the drug robot Dosell as well as the SaaS solution Pilloxa with the smart pillbox. The company's solutions reduce the risk of incorrect medication in the home, increase compliance, relieve public health care, increase the quality of life for patients and create a safer environment for relatives.</p><p>The customers consist of private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group primarily sells through well-established partners who already have long and deep customer relationships with the prioritized customer groups. The head office is in Stockholm.</p><p>iZafe Group AB has been listed on the Nasdaq First North Growth Market since 2018. Mangold Fondkommission AB is the company's Certified Adviser. Further information is available at <a rel="noopener" href="http://www.izafegroup.com">www.izafegroup.com</a></p></div><div class="mfn-footer mfn-regulatory mfn-regulatory-mar"><p><em>This information is information that iZafe Group is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-10-12 17:51 CEST.</em></p></div><div class="mfn-footer mfn-attachment mfn-attachment-image"><p><strong class="mfn-heading-1">Image Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/ca1d7d5e-020e-46cb-a8e1-23410896d167/dosell-vgr.png">Dosell VGR</a></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/bcd777a5-5c10-4b51-a75c-16a165c56ac0/izafe-group-in-collaboration-with-atea-sweden-has-won-a-procurement-potentially-worth-42-52-msek.pdf" class="mfn-generated mfn-primary">iZafe Group, in collaboration with Atea Sweden, has won a procurement potentially worth 42-52 MSEK.</a></p></div>

iZafe Group, in collaboration with Atea Sweden, has won a procurement potentially worth 42-52 MSEK.

Talouden myyttejä murtamassa: Saksan teollisuus on menneen talven lumia

Federal Reserven korkopäätös: Riidankylväjät vauhdissa

On pakko painaa pitkää päivää? Ekonomisti fundeeraa

Taloustieteen myyttejä murtamassa: Datakeskusinvestoinnit johtavat aina vain parempaan tekoälyyn

Nousuviikko takana, USA:n työllisyystaantuma ei edelleenkään luvuissa